Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor

European Journal of Dermatology

Volumn 24, Issue 6, 2014, Pages 702-703

  Kido Nakahara, Makiko ^a   Nakahara, Takeshi ^a   Miki, Masami ^b   Igarashi, Hisato ^b   Ito, Tetsuhide ^b   Furue, Masutaka ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; EVEROLIMUS; GASTRIN; GLUCAGON; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; OCTREOTIDE; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOSTATIN; STEROID; SUNITINIB; SYNAPTOPHYSIN; ZINC ION;

ADULT; ALBUMIN BLOOD LEVEL; BIOPSY; CASE REPORT; CHEILITIS; DISEASE ASSOCIATION; FEMALE; GASTRIN BLOOD LEVEL; GASTRIN RELEASE; GASTRINOMA; GLUCAGON RELEASE; GLUCAGONOMA; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; LETTER; MIDDLE AGED; NECROLYTIC MIGRATORY ERYTHEMA; PANCREATIC NEUROENDOCRINE TUMOR; PARAKERATOSIS; PHENOTYPIC VARIATION; RASH; ZINC BLOOD LEVEL; BLOOD; COMPLICATION; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PARANEOPLASTIC SYNDROMES; PHENOTYPE; SECRETION (PROCESS);

ADULT; FEMALE; GASTRINOMA; GASTRINS; GLUCAGON; GLUCAGONOMA; HUMANS; NECROLYTIC MIGRATORY ERYTHEMA; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PARANEOPLASTIC SYNDROMES; PHENOTYPE;

EID: 84922688955     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2443     Document Type: Letter

References (8)

1. Johnson SM, Smoller BR, Lamps LW, Horn TD. Necrolytic migratory erythema as the only presenting sign of a glucagonoma. J Am Acad Dermatol 2003; 49: 325-8.
2. Ito T, Igarashi H, Jensen RT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances. J Gastroenterol 2012; 47: 941-60.
3. Mullans EA, Cohen PR. Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema. J Am Acad Dermatol 1998; 38: 866-73.
4. Technau K, Renkl A, Norgauer J, Ziemer M. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma. Eur J Dermatol 2005; 15: 110-2.
5. Tseng HC, Liu CT, Ho JC, Lin SH. Necrolytic migratory erythema and glucagonoma rising from pancreatic head. Pancreatology 2013; 13: 455-7.
6. Ohneda A, Otsuki M, Fujiya H, Yaginuma N, Kokubo T, Ohtani H. A malignant insulinoma transformed into a glucagonoma syndrome. Diabetes 1979; 28: 962-9.
7. Kobayashi M, Kawa S, Kobayashi M, Imai Y, Sodeyama T, Kiyosawa K. Malignant insulinoma presenting a non-functioning metastatic liver tumor 14 years after resection of the primary tumor. J Gastroenterol 1998; 33: 891-4.
8. Stephen AE, Hodin RA. Neuroendocrine tumors of the pancreas, excluding gastrinoma. Surg Oncol Clin N Am 2006; 15: 497-510.